News

Before joining Sloning, Mr Merry has held several executive positions in the field of sales and marketing with companies such as Applied Biosystems, Millipore, or Qiagen, where he

Circassia has initiated a Phase II clinical study of its ToleroMune technology in allergy patients with asthma. The trial builds on positive Phase II results that demonstrated the

Under the terms of the agreement, DTL will market the Sonablate 500 high intensity focused ultrasound (HIFU) system as a mobile, ‘fee for use’ service to hospitals in

The agreement was entered into to advance the development of NovaBay’s Aganocide compounds by integrating extensive and ongoing clinical work at the university with NovaBay’s development program. Under

Nymox Pharmaceutical has received the investigational review board’s approval to begin NX02-0017, the first Phase III US clinical trial for NX-1207, the company’s investigational drug for benign prostatic

Waban, headquartered in Cambridge, Massachusetts, and with operations in Mumbai, India, will become the Waban Software Group within Phase Forward. The Waban Software acquisition extends Phase Forward’s portfolio

Mohd Asif, CFO of Halo Pharmaceutical, said: “Provident is a respected local bank that understands the New Jersey market and the needs of New Jersey’s pharmaceutical companies. That’s

After graduating from the Richard Ivey School of Business, Mr Thrasher spent over 30 years working around the globe for such blue chip companies as General Foods, McCormick,

According to Covidien, the SILS port is a single, flexible port that may be fitted through a small incision in the umbilicus that results in a single ‘hidden